Sign In
Buy PRQR
$1.47
+0 (+0%)
At Close: Jun 03, 2026
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
08:00am, Thursday, 01'st May 2025
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 01, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V.
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth
07:00am, Monday, 14'th Apr 2025
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV.
ProQR (PRQR) Reports Q4 Loss, Lags Revenue Estimates
10:02am, Thursday, 13'th Mar 2025
ProQR (PRQR) came out with a quarterly loss of $0.10 per share versus the Zacks Consensus Estimate of a loss of $0.07. This compares to loss of $0.08 per share a year ago.
ProQR Announces Year End 2024 Operating and Financial Results
07:00am, Thursday, 13'th Mar 2025
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 13, 2025 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies bas
ProQR Appoints Peter A. Beal, PhD, as Chief ADAR Scientist
08:00am, Tuesday, 10'th Dec 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies base
ProQR Announces Closing of Underwritten Public Offering and Concurrent Private Placement
04:45pm, Friday, 25'th Oct 2024
LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 25, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through transformative RNA t
ProQR Prices $75 Million Underwritten Public Offering and Concurrent Private Placement
10:15pm, Tuesday, 22'nd Oct 2024
LEIDEN, Netherlands and CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through transformative RNA thera
ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares
04:01pm, Tuesday, 22'nd Oct 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq: PRQR) (“ProQR”), a company dedicated to changing lives through transformative RNA therap
ProQR Highlights Upcoming Presentation at 20th Annual Meeting of the Oligonucleotide Therapeutics Society
08:00am, Monday, 07'th Oct 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., Oct. 07, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, toda
Best Momentum Stocks to Buy for October 2nd
11:17am, Wednesday, 02'nd Oct 2024
BRFS, SNAX, and PCQR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 2, 2024.
ProQR Announces Webcast Presentation at the 2024 Cantor Global Healthcare Conference
04:30pm, Tuesday, 10'th Sep 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., Sept. 10, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies bas
ProQR Therapeutics N.V. (PRQR) ASGCT Investor Webcast (Transcript)
05:57pm, Saturday, 11'th May 2024
ProQR Therapeutics N.V. (NASDAQ:PRQR ) ASGCT Investor Webcast May 9, 2024 8:00 AM ET Company Participants Sarah Kiely - IR Daniel de Boer - Founder and CEO Gerard Platenburg - Chief Scientific Officer
ProQR Announces First Quarter 2024 Operating and Financial Results
07:00am, Thursday, 09'th May 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., May 09, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies bas
ProQR Nominates Martin Maier, PhD to Board and Announces Annual Meeting of Shareholders to be Held May 22, 2024
07:00am, Tuesday, 23'rd Apr 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 23, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV. (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies bas
ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting
04:31pm, Monday, 22'nd Apr 2024
LEIDEN, Netherlands & CAMBRIDGE, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- ProQR Therapeutics NV (Nasdaq: PRQR) (ProQR), a company dedicated to changing lives through transformative RNA therapies, tod
